Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pathalys Raises $105m To Pave Path Toward US Commercialization
Series B Follows $150m Series A In January 2023
Aug 20 2024
•
By
Mandy Jackson
Pathalys raised money for next steps: completing Phase III, filing for approval and commercialization • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Financing
More from Business